As of Feb 10
| +0.06 / +0.10%|
The 21 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 73.00, with a high estimate of 100.00 and a low estimate of 57.00. The median estimate represents a +19.52% increase from the last price of 61.08.
The current consensus among 24 polled investment analysts is to Buy stock in Bristol-Myers Squibb. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.